Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Oerth Bio
company
About
Oerth Bio is a agriculture-focused biotech firm.
- 1 - 10
Highlights
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop new human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$55M
Oerth Bio has raised a total of
$55M
in funding over 2 rounds. Their latest funding was raised on
Feb 27, 2020 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 27, 2020 | Corporate Round | $55M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Oerth Bio is funded by 1 investors.
Bayer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Bayer
|
— | Corporate Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
